Retroperitoneal neurofibrosarcoma in a patient with neurofibromatosis 2: A case report and review of the literature

Pediatric Pathology and Molecular Medicine

Volumn 22, Issue 5, 2003, Pages 375-381

  Chen, Yu ^a   Diamond, Alan S ^a   Vaheesan, Kirubahara R ^a   Schneider, Steven ^a   Valderrama, Elsa ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Immunohistochemistry; Neurofibromatosis type 2; Neurofibrosarcoma

Indexed keywords

ACOUSTIC NEURINOMA; ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CASE REPORT; FEMALE; HUMAN; MALIGNANT TRANSFORMATION; MENINGIOMA; NEURILEMOMA; NEUROFIBROMATOSIS; NEUROFIBROSARCOMA; PRIORITY JOURNAL; RETROPERITONEAL TUMOR; SPINAL CORD TUMOR;

ADULT; FEMALE; FIBROSARCOMA; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROFIBROMATOSIS 2; RETROPERITONEAL NEOPLASMS;

EID: 0141891288     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/15227950307704     Document Type: Article

References (25)

1. Evans DGR, Hjison Sm, Donnai D, Neary W, Blair V, Teare D, Newton V, Harris R. A clinical study of type 2 neurofibromatosis. QJ Med. 1992;304:603-618.
2. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N. Neurofibromatosis type 2: Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet. 1994;52:450-461.
3. Evans DGR, Huson SM, Donnai D, Neary W, Blair V, Teare D, Newton V, Harris R. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet. 1994;29:841-846.
4. Eldridge R. Central neurofibromatosis with bilateral acoustic neuroma. Adv Neuropathol. 1981;29:57-65
5. Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med. 1981;305:1617-1627.
6. Martuza RL, Eldridge R. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med. 1988;318:684-688.
7. Lee M, Rezai AR, Freed D, Epstein FJ. Intramedullary spinal cord tumor in neurofibromatosis. Neurosurgery. 1996;38:32-37.
8. Hruban RH, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. Cancer. 1990;66:1253-1265.
9. Ducatman BS, Scheithauer BW, Piepgras DG, Reimen HM, Ilstrup DM. Malignant peripheral nerve sheath tumor. Cancer. 1986;57:2006-2021.
10. Ducatman BS, Scheithauer BW. Postirradiation neurofibrosarcoma. Cancer. 1983;51:1028-1033.
11. Newbould MJ, Wilkinson N, Mene A. Post-irradiation malignant peripheral nerve sheath tumor: A report of two cases. Histopathology. 1990;17:263-265.
12. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technique. Am J Clin Pathol. 1981;75:816-21.
13. Gutman DH, Aynsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Visckochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. J Am Med Assoc. 1997;278:51-57.
14. Birch R. Peripheral nerve tumors. In: Dyck PJ, Thomas PK (eds). Peripheral neuropathy, 3rd ed. 1993; Philadelphia: WB Saunders.
15. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Rechlinghausen neurofibromatosis: survival and malignant neoplasm. N Engl J Med. 1986;314:1010-1015.
16. Eldridge R. Central neurofibromatosis with bilateral acoustic neuroma. Adv Neurol. 1981;29:57-65.
17. Poyhonen M, Niemela S, Herva R. Risk of malignancy and death in neurofibromatosis Arch Path Lab. Med. 1997;121:139-143.
18. Seppala MT, Haltia MJJ, Sankila RJ, Jaaskelainen JE, Heiskanen O. Long-term outcome after removal of spinal schwannoma: a clinicopathological study of 187 cases. J Neurosurg. 1995;83:621-626.
19. Higami Y, Shimokawa I, Kishikawa M, Okimoto T, Ohtani H, Tomita M, Tsujino A, Ikeda T. Malignant peripheral nerve sheath tumors developing multifocally in the central nervous system in a patient with neurofibromatosis type 2. Clin Neuropathol. 1998;17:115-20.
20. Guccion JG, Enzinger FM. Malignant schwannoma associated with von Ricklinghausen disease. Virchows Arch (Pathol Anat.). 1979;83:43-57.
21. Sangueza OP, Requena L. Neoplasms with neural differentiation: A review Part II: Malignant neoplasms. Am J Dermatopathol. 1998;20:89-102.
22. Halliday AL, Sobel RA, Martuza RL. Benign spinal nerve sheath tumors: their occurrence sporadically and in the neurofibromatosis type 1 and 2. J Neurosurg. 1991;74:248-253.
23. Troffater JA, MacCollin MM, Rutter JL, Murrell JR, Duyan MP, Parry DM, Eldridge R, Kley N, Menon A, Pulaski K, Haase VH, Ambrose CM, Monroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF. A novel moesin, ezrin-, radixin-likee gene is candidate for the neurofibromatosis type 2. Cell. 1993;72:791-800.
24. Fountain JW, Wallece MR, Bruce MA, Seizinger BR, Menon AG, Gusella JF, et al. Physical mapping of a translocation breakpoint in neurofibromatosis. Science. 1989;244:1085-1087.
25. Gutman DH, Collins FS. The neurofibromatosis type I gene and its protein product, neurofibromin. Neuron. 1993;10:335-343.